Nh. Zaidi et al., QUANTITATIVE IMMUNOHISTOCHEMICAL ESTIMATES OF O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE EXPRESSION IN NORMAL AND MALIGNANT HUMAN COLON, Clinical cancer research, 2(3), 1996, pp. 577-584
A major mechanism of resistance to nitrosoureas is O-6-alkylguanine-DN
A-alkyltransferase. The alkyltransferase biochemical assay measures me
an tissue activity but requires availability of fresh tissue and canno
t assess tumor heterogeneity, an important component of tumor resistan
ce to alkylating agents. We assessed the levels of alkyltransferase in
human colon carcinoma and normal colon by biochemical assay, Western
blot, conventional immunohistochemistry, and quantitative immunohistoc
hemistry (using 5H7 and mT3.1 monoclonal IgGs) to correlate whole tiss
ue levels with cell-specific expression. Alkyltransferase activity was
18.0 +/- 4.6 fmol/mu g DNA in normal colon and 15.0 +/- 6.5 fmol/mu g
DNA in tumors. By Western blot estimates, alkyltransferase in normal
colon was 14.8 +/- 4.2 fmol/mu g DNA and in tumors was 16.2 +/- 7.8 fm
ol/mu g DNA. Alkyltransferase estimates by biochemical and Western blo
ts were correlated strongly (P < 0.0001). Conventional immunohistochem
istry demonstrated that alkyltransferase was predominantly nuclear and
in normal colon was concentrated in glandular epithelial mucosal cell
s close to the lumen, whereas in tumors, expression was heterogenous b
ut localized to malignant epithelial cells. Two parameters of quantita
tive immunohistochemistry, integrated gray and mean gray, were correla
ted strongly with each other (P < 0.002) and with biochemical and West
ern blot estimates (P = 0.004-0.04). Thus, quantitative immunohistoche
mical estimates of alkyltransferase in fixed tissues are a reasonable
alternative to biochemical analysis and have an added advantage of ide
ntifying heterogeneity of alkyltransferase expression in tumors.